Sanofi’s colorectal cancer drug gains FDA approval
August 6, 2012Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer
The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …
Talentmark appoints director of Managed Services
August 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark
Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …
ABPI outlines vision for drug pricing reform
August 3, 2012Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing
The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
GSK submits melanoma drugs for regulatory approval
August 3, 2012Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology
GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …
Government healthcare fund pays up
August 3, 2012Research and Development, Sales and Marketing ABPI, MRC, SMEs, government
A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …
Teva makes two senior executive appointments
August 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Aharon (Arik) Yaari, Carlo De Notaristefani, Teva
Teva has announced the appointments of Dr Carlo De Notaristefani as president and chief executive of Global Operations, and Aharon …
Susan Thiele appointed US head of healthcare
August 3, 2012Medical Communications Hill+Knowlton, susan thiele
Communications firm Hill+Knowlton Strategies has announced the appointment of Susan Thiele as US healthcare practice leader. Thiele has been with …
Pfizer Sandwich site sold to private consortium
August 3, 2012Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts
The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
Shire posts strong quarter results
August 2, 2012Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results
Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …
Bristol-Myers Squibb halts Hep C pill study
August 2, 2012Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension
Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …
Government to harness NHS patient data for research use
August 2, 2012Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data
The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …
New UK drug pricing system will ‘stifle innovation’
August 2, 2012Sales and Marketing ABPI, PPRS, UK government, VBP
The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …
Daiichi Sankyo: breaking down barriers with social media
August 1, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media
Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …
Olympics to kick-start research ventures
August 1, 2012Research and Development, Sales and Marketing GSK, London 2012, Olympics, research
London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …
MRN posts 533% growth in first five years
August 1, 2012Research and Development clinical trials, growth, results
From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …
Lucid Communication joins forces with Luther Pendragon
August 1, 2012Medical Communications Lucid communications, Luther Pendragon
Communciations agency Luther Pendragon has purchased PR firm Lucid Communication to help expand its US client base. The deal will …
Pfizer’s RA pill impresses in Phase III
August 1, 2012Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA
Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …
Just:: Health PR promotes Laura Chambers to its senior team
July 31, 2012Medical Communications Just:: Health PR, Laura Chambers, just health pr
Just:: Health PR has promoted Laura Chambers to the position of director. Chambers will join fellow directors Tamsin Tierney and …
Lipitor loss continues to hit Pfizer sales
July 31, 2012Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2
Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …
Dendreon slashes staff and closes facility
July 31, 2012Manufacturing and Production, Sales and Marketing Dendreon, M&P, Provenge, prostate cancer
Cancer vaccine specialist Dendreon has said it will slash 600 jobs and close one of its three manufacturing facilities in …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
